mitapivat

FDA Drug Profile — PYRUKYND, AQVESME

Drug Details

Generic Name
mitapivat
Brand Names
PYRUKYND, AQVESME
Application Number
NDA216196
Sponsor
Agios Pharmaceuticals, Inc.
NDC Codes
7
Dosage Forms
KIT, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
MITAPIVAT

Indications and Usage

1 INDICATIONS AND USAGE PYRUKYND is indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency. ( 1 )